STUDIES ON HUMAN ANTIBODIES
Insoluble blood group substances prepared by copolymerization of soluble blood group substances with N-carboxy-L-leucine anhydride were used to absorb blood group antibodies from two human, high-titered anti-A sera. After the absorbants were washed free of nonspecific serum proteins, blood group ant...
Saved in:
Published in | The Journal of experimental medicine Vol. 123; no. 6; pp. 1061 - 1081 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
01.06.1966
|
Online Access | Get full text |
Cover
Loading…
Abstract | Insoluble blood group substances prepared by copolymerization of soluble blood group substances with N-carboxy-L-leucine anhydride were used to absorb blood group antibodies from two human, high-titered anti-A sera. After the absorbants were washed free of nonspecific serum proteins, blood group antibodies were eluted either with pH 3.62 acetate buffer, or at neutral pH with monosaccharide haptens of the A or B antigenic determinants (N-acetyl-D-galactosamine or D-galactose respectively). The purified anti-A antibodies were characterized, immunoelectrophoretically, as γM-, γA-, and γG-immunoglobulins. These were further separated into γM- and γG-fractions by gel filtration or density gradient centrifugation. Both γM- and one of the two γG-antibody fractions contained K and L light chain determinants; the remaining γG-fraction was comprised, almost totally, of type K molecules.
Precipitability of the purified anti-A immunoglobulins by blood group A substance varied from 43 to 89%. The agglutinating activity per unit N of the isolated γG-anti-A was found to equal, in one case, and to exceed, in the second, that of the γM-antibodies from the same individuals.
The marked differences between γM- and γG-antibody fractions in quantitative hapten inhibition studies were interpreted to mean that the antibody-combining site of the isolated eluted γG-anti-A was significantly larger than that of the eluted γM-anti-A. Whether these data connote differences in combining site size between entire immunoglobulin classes in an individual serum or simply reflect the properties of highly selected antibody populations cannot be stated at present. |
---|---|
AbstractList | Insoluble blood group substances prepared by copolymerization of soluble blood group substances with N-carboxy-L-leucine anhydride were used to absorb blood group antibodies from two human, high-titered anti-A sera. After the absorbants were washed free of nonspecific serum proteins, blood group antibodies were eluted either with pH 3.62 acetate buffer, or at neutral pH with monosaccharide haptens of the A or B antigenic determinants (N-acetyl-D-galactosamine or D-galactose respectively). The purified anti-A antibodies were characterized, immunoelectrophoretically, as γM-, γA-, and γG-immunoglobulins. These were further separated into γM- and γG-fractions by gel filtration or density gradient centrifugation. Both γM- and one of the two γG-antibody fractions contained K and L light chain determinants; the remaining γG-fraction was comprised, almost totally, of type K molecules.
Precipitability of the purified anti-A immunoglobulins by blood group A substance varied from 43 to 89%. The agglutinating activity per unit N of the isolated γG-anti-A was found to equal, in one case, and to exceed, in the second, that of the γM-antibodies from the same individuals.
The marked differences between γM- and γG-antibody fractions in quantitative hapten inhibition studies were interpreted to mean that the antibody-combining site of the isolated eluted γG-anti-A was significantly larger than that of the eluted γM-anti-A. Whether these data connote differences in combining site size between entire immunoglobulin classes in an individual serum or simply reflect the properties of highly selected antibody populations cannot be stated at present. |
Author | Kaplan, Manuel E. Kabat, Elvin A. |
Author_xml | – sequence: 1 givenname: Manuel E. surname: Kaplan fullname: Kaplan, Manuel E. – sequence: 2 givenname: Elvin A. surname: Kabat fullname: Kabat, Elvin A. |
BookMark | eNotz71OwzAUBWALtRJpy8rCkhdwuNf_HkMpNFJJhiaz5TqOREVbFE-8PYlgujpXOkf6VmRxvV0jIY8IBYIRz-d4KZDxQk1R4R3JUAqgVnKzIBkAYxQB9D1ZpXQGQCGkysjTse1eq90xb-p8332UdV7WbfXSzL8NWQ7-K8WH_7sm3duu3e7poXmvtuWBBmQCKZPyhEoL2zNALX2wYKMJbMCTBc9EVN7goHsbRC84NxCjUnaqRBst15qvSfG3G8ZbSmMc3Pf4efHjj0NwM81NNDfRnHIzjf8CLWs-hA |
CitedBy_id | crossref_primary_10_1016_0008_8749_77_90284_2 crossref_primary_10_1016_0014_5793_75_80948_3 crossref_primary_10_1111_j_1749_6632_1970_tb55968_x crossref_primary_10_1016_0161_5890_94_90067_1 crossref_primary_10_1016_S0021_9258_19_41666_9 crossref_primary_10_1016_0003_9861_70_90463_7 crossref_primary_10_1038_226855a0 crossref_primary_10_1016_0003_9861_81_90272_1 crossref_primary_10_1016_0014_5793_70_80354_4 crossref_primary_10_1111_j_1749_6632_1974_tb53038_x crossref_primary_10_1016_0014_5793_80_80953_7 crossref_primary_10_1016_S0014_5793_98_00617_6 crossref_primary_10_1016_0925_4439_96_00016_6 crossref_primary_10_1016_0003_9861_81_90273_3 crossref_primary_10_1016_0022_1759_77_90002_3 crossref_primary_10_1111_j_1749_6632_1974_tb53031_x crossref_primary_10_1016_S0008_6215_00_80982_9 crossref_primary_10_1111_j_1749_6632_1970_tb55965_x crossref_primary_10_1002_eji_1830070403 crossref_primary_10_1016_0300_9629_83_90044_0 crossref_primary_10_1111_j_1365_3083_1976_tb03833_x crossref_primary_10_1515_bchm2_1983_364_1_655 crossref_primary_10_1016_0024_3205_95_02164_E crossref_primary_10_1016_0304_4165_94_00132_H crossref_primary_10_1111_j_1432_1033_1980_tb04506_x crossref_primary_10_1111_j_1365_2222_1976_tb01942_x crossref_primary_10_1111_j_1432_1033_1969_tb19641_x crossref_primary_10_1016_0003_9861_77_90176_X crossref_primary_10_1016_S0021_9258_18_96141_7 crossref_primary_10_1016_0019_2791_70_90054_6 crossref_primary_10_1002_eji_1830080512 crossref_primary_10_1016_0019_2791_71_90428_9 crossref_primary_10_1016_0019_2791_70_90059_5 crossref_primary_10_1080_03602548108066012 crossref_primary_10_1016_0304_4165_94_00130_P crossref_primary_10_1016_0005_2795_80_90045_8 crossref_primary_10_1016_0003_9861_79_90646_5 crossref_primary_10_1016_0003_9861_82_90099_6 crossref_primary_10_1111_j_1749_6632_1974_tb53042_x crossref_primary_10_1016_0019_2791_68_90076_1 crossref_primary_10_1016_0304_4165_69_90102_0 crossref_primary_10_1016_S0021_9258_17_37773_6 crossref_primary_10_1016_0014_5793_95_00106_J crossref_primary_10_1002_ijc_2910030412 crossref_primary_10_1089_cdd_1987_4_245 crossref_primary_10_1002_jss_400080107 crossref_primary_10_1016_0014_5793_96_00320_1 |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.1084/jem.123.6.1061 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1540-9538 |
EndPage | 1081 |
ExternalDocumentID | 10_1084_jem_123_6_1061 |
GroupedDBID | --- -~X .55 .GJ 0VX 18M 29K 2WC 36B 53G 5GY 5RE 5VS AAYXX ABOCM ABZEH ACGFO ACNCT ACPRK ADBBV AENEX AFFNX AFOSN AFRAH AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C45 CITATION CS3 D-I DIK DU5 E3Z EBS EMB F5P F9R FRP GX1 H13 HYE IH2 K-O KQ8 L7B MVM N9A O5R O5S OK1 P2P P6G R.V RHF RHI RPM SJN TR2 TRP UHB VH1 W8F WOQ X7M ZGI |
ID | FETCH-LOGICAL-c1241-255b16749d20175ac909e8c2f1b90a24e6a81f7d9c4d43380ee669b16e9e93773 |
ISSN | 0022-1007 |
IngestDate | Thu Sep 26 19:54:50 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1241-255b16749d20175ac909e8c2f1b90a24e6a81f7d9c4d43380ee669b16e9e93773 |
OpenAccessLink | https://rupress.org/jem/article-pdf/123/6/1061/1082407/1061.pdf |
PageCount | 21 |
ParticipantIDs | crossref_primary_10_1084_jem_123_6_1061 |
PublicationCentury | 1900 |
PublicationDate | 1966-06-01 |
PublicationDateYYYYMMDD | 1966-06-01 |
PublicationDate_xml | – month: 06 year: 1966 text: 1966-06-01 day: 01 |
PublicationDecade | 1960 |
PublicationTitle | The Journal of experimental medicine |
PublicationYear | 1966 |
SSID | ssj0014456 |
Score | 1.2044795 |
Snippet | Insoluble blood group substances prepared by copolymerization of soluble blood group substances with N-carboxy-L-leucine anhydride were used to absorb blood... |
SourceID | crossref |
SourceType | Aggregation Database |
StartPage | 1061 |
Title | STUDIES ON HUMAN ANTIBODIES |
Volume | 123 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PT4MwFG50JsaL8WfUqeFg4mEBC-tKe5w6s7mMXbZkNwLlcTATF7N58K_3FRiwucOUQ0MKr6T9yuvXvvdaQu6aVAnRcpXpgAsmw8sUigozlpQxFUY8ilIvX493x-x10pqUByem0SXz0FLfG-NK_oMq5iGuOkr2D8gWhWIG3iO-mCLCmG6FcU7nGkOv0R0P2l6j7Y16j8OC4r2VXaFCPFc29V-3rfeD2TRbEx0EyQKmjY5VPgqDeeYK9qVXSaxyxQB_MF56NlU8-LV3RDYG5IqPUW3KFSuaMQsFzrtAVc_piWRlzLRpdu7KL31MBdP6GN4tLMviVilX3fh6bUAq3ARTA7lgPsr7KO9zX8vvkj0HtYr233vu9QuTEWPpUb1F5ZY7dAr2sPr9CgOpUInRETnMoTDaGaDHZAeSE7I_yJE4JfUcV2PoGSmuRonrGRm_dEZPXTM_xMJUSJ1sE6dsoY70kBFSLbcVKEklCOXEdihp4DDggbBjN5KKRazZFBSAc4kiIAGpo9s8J7XkI4ELYkgkHCyCMAacliPvCjjYTswdFsW2chVckvtlxfxZtleJv7kJr7Z-s04Oyi50TWrzzwXcIA2bh7dp8_8APB4mvQ |
link.rule.ids | 315,783,787,27938,27939 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=STUDIES+ON+HUMAN+ANTIBODIES&rft.jtitle=The+Journal+of+experimental+medicine&rft.au=Kaplan%2C+Manuel+E.&rft.au=Kabat%2C+Elvin+A.&rft.date=1966-06-01&rft.issn=0022-1007&rft.eissn=1540-9538&rft.volume=123&rft.issue=6&rft.spage=1061&rft.epage=1081&rft_id=info:doi/10.1084%2Fjem.123.6.1061&rft.externalDBID=n%2Fa&rft.externalDocID=10_1084_jem_123_6_1061 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1007&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1007&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1007&client=summon |